LISDEXAMFETAMINE DIMESYLATE
NDC 57664-087, LISDEXAMFETAMINE DIMESYLATE, tablet, chewable, from Sun Pharmaceutical Industries, Inc..
- Product NDC
- 57664-087
- Status
- Listed
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Dosage form
- TABLET, CHEWABLE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214134
- DEA schedule
- CII
curl https://api.healthcare.dev/v1/drugs/ndc/57664-087 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LISDEXAMFETAMINE DIMESYLATE50 mg/1
Pharmacologic classes
Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 57664-087-88 | 57664008788 | 100 TABLET, CHEWABLE in 1 BOTTLE (57664-087-88) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/da3148af-f9b6-4725-adae-3595b4c7dc4bNADAC price for package 57664008788
GET /v1/drugs/nadac/57664008788
Use it
Look up 57664-087 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/57664-087 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 57664-087. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.